Viracta Therapeutics, Inc. (VIRX)
OTCMKTS · Delayed Price · Currency is USD
0.0150
-0.0001 (-0.66%)
Jul 1, 2025, 1:11 PM EDT

Viracta Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018
Period Ending
Jul '25 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018
12256136--
Upgrade
Market Cap Growth
-77.27%-60.52%-59.05%---
Upgrade
Enterprise Value
-4-10-1136--
Upgrade
Last Close Price
0.020.571.463.65--
Upgrade
PB Ratio
-0.101.200.911.44--
Upgrade
P/TBV Ratio
-1.711.001.53--
Upgrade
Debt / Equity Ratio
-2.561.400.410.060.170.01
Upgrade
Quick Ratio
0.741.419.2311.407.497.61
Upgrade
Current Ratio
0.761.439.3611.597.517.64
Upgrade
Return on Equity (ROE)
-370.13%-128.57%-63.29%-174.44%-71.41%-186.10%
Upgrade
Return on Assets (ROA)
-66.76%-41.50%-30.92%-31.32%-35.23%-63.93%
Upgrade
Return on Capital (ROIC)
-89.60%-48.69%-33.98%-34.29%-39.49%-77.20%
Upgrade
Earnings Yield
-6641.40%-231.91%-88.22%-84.27%--
Upgrade
FCF Yield
--181.82%-63.66%-14.03%--
Upgrade
Buyback Yield / Dilution
-1.99%-2.21%-18.58%-9714.39%86.22%-145.73%
Upgrade
Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.